Photys Therapeutics Debuts with $75 Million Series A Funding to Advance New Class of Bifunctional Molecules for Precision Phosphorylation to Modulate and Repair Disease-Driving Proteins September 8, 2022
Werewolf Therapeutics Announces Initiation of Patient Dosing in Phase 1/1b Clinical Trial of WTX-124 for the Treatment of Patients with Selected Solid Tumors September 2, 2022
In a Recently Published Clinical Study, Colorescience® Total Eye® Firm & Repair Cream Demonstrated Significant Improvements in the Appearance of Overall Eye Area August 26, 2022
Pyxis Oncology Reports Financial Results for the Second Quarter Ended June 30, 2022 and Provides Pipeline Update August 15, 2022
